A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, plasmablastic lymphoma	Recruiting	Early phase 1	2026-06-01		NCT04139304

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AIDS and Cancer Specimen Resource	1
AIDS Malignancy Consortium	11
Janssen Scientific Affairs, LLC	37
Memorial Sloan Kettering Cancer Center	753
Montefiore Medical Center	93
National Cancer Institute (NCI)	3015
The Emmes Company, LLC	17

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Johns Hopkins University/Sidney Kimmel Cancer Center	Baltimore	United States	2
Memorial Sloan Kettering Cancer Center	New York	United States	60
The Ohio State University	Columbus	United States	191
The University of Texas MD Anderson Cancer Center	Houston	United States	207
University of Illinois at Chicago	Chicago	United States	85
University of Miami Miller School of Medicine	Miami	United States	28
University of North Carolina - Chapel Hill	Chapel Hill	United States	2
University of Pennsylvania	Philadelphia	United States	507